Hookipa Pharma Inc

+$0.72 (+4.28%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell HOOK and other stocks, options, and ETFs commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT.

CEO

Jörn Aldag

Employees

109

Headquarters

New York, New York

Founded

2011

HOOK Key Statistics

Market Cap

499.91M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

253.70K

High Today

$18.07

Low Today

$16.56

Open Price

$17.00

Volume

404.93K

52 Week High

$18.09

52 Week Low

$8.10

HOOK News

BenzingaMay 12

Why HOOKIPA Pharma's Stock Is Trading Higher Today - Craft Brewers Alliance

HOOKIPA Pharma (NASDAQ:HOOK) shares are trading higher after the company reported better-than-expected Q1 sales results. HOOKIPA Pharma's stock is trading up 4

BenzingaMay 12

HOOKIPA Pharma: Q1 Earnings Insights

Shares of HOOKIPA Pharma (NASDAQ:HOOK) fell 6.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 23.26%

Analyst Ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

HOOK Earnings

-$0.65

-$0.53

-$0.40

-$0.28

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.53 per share

Actual

-$0.53 per share